Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dermata Therapeutics, Inc. stock logo
DRMAW
Dermata Therapeutics
$0.00
-46.7%		$0.01
$0.00
▼
$0.03
N/AN/A10,218 shs602 shs
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
$0.02
+10.3%		$0.02
$0.01
▼
$0.09
N/AN/A23,625 shs30,061 shs
PRENW
Prenetics Global
$0.01
-29.6%		$0.01
$0.01
▼
$0.04
N/AN/A39,466 shs11,420 shs
Waldencast plc stock logo
WALDW
Waldencast
$0.04
+2.5%		$0.04
$0.02
▼
$0.07
N/AN/A51,571 shs509 shs
The Best Nuclear Energy Stocks to Buy Cover
The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dermata Therapeutics, Inc. stock logo
DRMAW
Dermata Therapeutics
0.00%-2.93%-40.33%-42.22%-61.48%
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
-6.03%+9.36%+1.08%+8.09%-7.43%
PRENW
Prenetics Global
-26.06%-16.10%-1.87%-41.01%-64.88%
Waldencast plc stock logo
WALDW
Waldencast
+5.57%-13.88%-16.47%-27.27%-18.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dermata Therapeutics, Inc. stock logo
DRMAW
Dermata Therapeutics
$0.00
-46.7%		$0.01
$0.00
▼
$0.03
N/AN/A10,218 shs602 shs
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
$0.02
+10.3%		$0.02
$0.01
▼
$0.09
N/AN/A23,625 shs30,061 shs
PRENW
Prenetics Global
$0.01
-29.6%		$0.01
$0.01
▼
$0.04
N/AN/A39,466 shs11,420 shs
Waldencast plc stock logo
WALDW
Waldencast
$0.04
+2.5%		$0.04
$0.02
▼
$0.07
N/AN/A51,571 shs509 shs
The Best Nuclear Energy Stocks to Buy Cover
The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dermata Therapeutics, Inc. stock logo
DRMAW
Dermata Therapeutics
0.00%-2.93%-40.33%-42.22%-61.48%
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
-6.03%+9.36%+1.08%+8.09%-7.43%
PRENW
Prenetics Global
-26.06%-16.10%-1.87%-41.01%-64.88%
Waldencast plc stock logo
WALDW
Waldencast
+5.57%-13.88%-16.47%-27.27%-18.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Dermata Therapeutics, Inc. stock logo
DRMAW
Dermata Therapeutics
0.00
N/AN/AN/A
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
0.00
N/AN/AN/A
PRENW
Prenetics Global
0.00
N/AN/AN/A
Waldencast plc stock logo
WALDW
Waldencast
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Dermata Therapeutics, Inc. stock logo
DRMAW
Dermata Therapeutics
N/AN/AN/AN/AN/AN/A
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
$2.02MN/AN/AN/AN/AN/A
PRENW
Prenetics Global
$120.07MN/AN/AN/AN/AN/A
Waldencast plc stock logo
WALDW
Waldencast
$272.07MN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Dermata Therapeutics, Inc. stock logo
DRMAW
Dermata Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A8/18/2026 (Estimated)
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
N/AN/AN/AN/AN/AN/AN/AN/AN/A
PRENW
Prenetics Global
N/AN/AN/AN/AN/AN/AN/AN/A8/18/2026 (Estimated)
Waldencast plc stock logo
WALDW
Waldencast
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest DSYWW, DRMAW, PRENW, and WALDW Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/18/2026N/A
Dermata Therapeutics, Inc. stock logo
DRMAW
Dermata Therapeutics
-$0.55N/AN/AN/AN/AN/A
8/18/2026N/A
PRENW
Prenetics Global
-$0.84N/AN/AN/A$49.85 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Dermata Therapeutics, Inc. stock logo
DRMAW
Dermata Therapeutics
N/AN/AN/AN/AN/A
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
N/AN/AN/AN/AN/A
PRENW
Prenetics Global
N/AN/AN/AN/AN/A
Waldencast plc stock logo
WALDW
Waldencast
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Dermata Therapeutics, Inc. stock logo
DRMAW
Dermata Therapeutics
N/A
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
N/A
PRENW
Prenetics Global
N/A
Waldencast plc stock logo
WALDW
Waldencast
N/A

Insider Ownership

CompanyInsider Ownership
Dermata Therapeutics, Inc. stock logo
DRMAW
Dermata Therapeutics
N/A
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
N/A
PRENW
Prenetics Global
N/A
Waldencast plc stock logo
WALDW
Waldencast
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Dermata Therapeutics, Inc. stock logo
DRMAW
Dermata Therapeutics
8N/AN/ANot Optionable
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
82N/AN/AN/A
PRENW
Prenetics Global
1N/AN/ANot Optionable
Waldencast plc stock logo
WALDW
Waldencast
284N/AN/ANot Optionable

Recent News About These Companies

Waldencast Finalizes Obagi Medical Sale, Refocuses on Milk Makeup and Repays Debt
July 30, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/waldencast-finalizes-obagi-medical-sale-refocuses-on-milk-makeup-and-repays-debt?utm_source=marketbeat.com&utm_medium=referral
Waldencast Closes $460 Million Sale of Obagi Medical, Refocuses on Milk Makeup
July 30, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/waldencast-closes-460-million-sale-of-obagi-medical-refocuses-on-milk-makeup?utm_source=marketbeat.com&utm_medium=referral
Waldencast Sets August AGM as Board Reshapes Around Milk Makeup Focus
July 13, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/waldencast-sets-august-agm-as-board-reshapes-around-milk-makeup-focus?utm_source=marketbeat.com&utm_medium=referral
Waldencast Shareholders Back Board Slate and Auditor at January 2026 AGM
January 15, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/waldencast-shareholders-back-board-slate-and-auditor-at-january-2026-agm?utm_source=marketbeat.com&utm_medium=referral
Waldencast Reports Q2 2025 Results and Strategic Updates
November 24, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/waldencast-reports-q2-2025-results-and-strategic-updates?utm_source=marketbeat.com&utm_medium=referral
Waldencast Expands U.S. Market Presence with Novaestiq Acquisition
November 24, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/waldencast-expands-u-s-market-presence-with-novaestiq-acquisition?utm_source=marketbeat.com&utm_medium=referral
Waldencast Enhances Financial Position with Trademark Sale and New Credit Facility
November 14, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/waldencast-enhances-financial-position-with-trademark-sale-and-new-credit-facility?utm_source=marketbeat.com&utm_medium=referral
Waldencast Gains FDA Approval for Obagi Injectable Gel, Expanding U.S. Market Reach
September 10, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/waldencast-gains-fda-approval-for-obagi-injectable-gel-expanding-u-s-market-reach?utm_source=marketbeat.com&utm_medium=referral
Waldencast Reports Strong H1 2025 Growth and Strategic Initiatives
August 18, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/waldencast-reports-strong-h1-2025-growth-and-strategic-initiatives?utm_source=marketbeat.com&utm_medium=referral
Waldencast Acquires Novaestiq and U.S. Rights to Saypha®
July 23, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/waldencast-acquires-novaestiq-and-u-s-rights-to-saypha?utm_source=marketbeat.com&utm_medium=referral
Waldencast initiated with a Hold at TD Cowen
December 17, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/waldencast-initiated-with-a-hold-at-td-cowen-1034140381
TD Cowen Initiates Coverage of Waldencast (WALD) with Hold Recommendation
December 17, 2024  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/td-cowen-initiates-coverage-of-waldencast-wald-with-hold-recommendation/ar-AA1vZTxF
Waldencast plc.: Waldencast Reports Q3 2024 Financial Results
November 21, 2024  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2024-11/63878387-waldencast-plc-waldencast-reports-q3-2024-financial-results-399.htm
Waldencast Acquisition (WALD) Gets a Buy from Telsey Advisory
November 21, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/waldencast-acquisition-wald-gets-a-buy-from-telsey-advisory-1034050511
Waldencast PLC (WALD) Q3 2024: Everything You Need to Know Ahead of Earnings
November 20, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/waldencast-plc-wald-q3-2024-122422855.html
Waldencast to Release Q3 Results and Host Call
November 15, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/waldencast-to-release-q3-results-and-host-call-1034011851
Obagi Medical Announces the Launch of ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate
September 9, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/obagi-medical-announces-the-launch-of-elastiderm-lift-up-sculpt-facial-moisturizer-and-elastiderm-advanced-filler-concentrate-1033757894
Waldencast plc (NASDAQ:WALD) Q2 2024 Earnings Call Transcript
August 29, 2024  |  msn.comhttps://www.msn.com/en-us/money/companies/waldencast-plc-nasdaq-wald-q2-2024-earnings-call-transcript/ar-AA1pDWaU
Why Nordstrom Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
August 28, 2024  |  msn.comhttps://www.msn.com/en-us/money/other/why-nordstrom-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket/ar-AA1pzvKJ
Waldencast plc's (NASDAQ:WALD) top owners are private companies with 29% stake, while 23% is held by insiders
July 22, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/waldencast-plcs-nasdaq-wald-top-130614082.html

Media Sentiment Over Time

Dermata Therapeutics stock logo

Dermata Therapeutics NASDAQ:DRMAW

$0.0035 0.00 (-46.69%)
As of 11:21 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Big Tree Cloud stock logo

Big Tree Cloud NASDAQ:DSYWW

$0.02 +0.00 (+10.34%)
As of 12:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Big Tree Cloud Holdings Limited manufactures and sells personal care products and other consumer goods. The company is based in Shenzhen, China. Big Tree Cloud Holdings Limited operates as a subsidiary of Ploutos Group Limited.

Prenetics Global NASDAQ:PRENW

$0.01 0.00 (-29.58%)
As of 12:52 PM Eastern

Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors. It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Waldencast stock logo

Waldencast NASDAQ:WALDW

$0.04 +0.00 (+2.50%)
As of 01:17 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Waldencast plc operates in the beauty and wellness industry. It engages in developing, acquiring, accelerating, and scaling various brands. The company provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. It also offers clean makeup products under the Milk Makeup brand. The company sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners. Waldencast plc was incorporated in 2020 and is headquartered in White Plains, New York.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas